Next Article in Journal
Forensic Analysis of Textile Synthetic Fibers Using a FT-IR Spectroscopy Approach
Previous Article in Journal
An Evidence-Based Review of Application Devices for Nitric Oxide Concentration Determination from Exhaled Air in the Diagnosis of Inflammation and Treatment Monitoring
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Antibacterial Activity Mode of Action of Plantaricin YKX against Staphylococcus aureus

1
Northwest Institute of Plateau Biology, Chinese Acadamy of Science, Xining 530001, China
2
Shaanxi Province Key Laboratory of Bioresources, 2011 QinLing-Bashan Mountains Bioresources Comprehensive Development C. I. C., Qinba State Key Laboratory of Biological Resources and Ecological Environment, College of Bioscience and Bioengineering, Shaanxi University of Technology, Hanzhong 723001, China
3
College of Health and Management, Shangluo University, Shangluo 724900, China
4
Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
5
Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Turkey
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(13), 4280; https://doi.org/10.3390/molecules27134280
Submission received: 31 May 2022 / Revised: 22 June 2022 / Accepted: 28 June 2022 / Published: 3 July 2022

Abstract

:
We aimed to evaluate the inhibitory effect and mechanism of plantaricin YKX on S. aureus. The mode of action of plantaricin YKX against the cells of S. aureus indicated that plantaricin YKX was able to cause the leakage of cellular content and damage the structure of the cell membranes. Additionally, plantaricin YKX was also able to inhibit the formation of S. aureus biofilms. As the concentration of plantaricin YKX reached 3/4 MIC, the percentage of biofilm formation inhibition was over 50%. Fluorescent dye labeling combined with fluorescence microscopy confirmed the results. Finally, the effect of plantaricin YKX on the AI-2/LuxS QS system was investigated. Molecular docking predicted that the binding energy of AI-2 and plantaricin YKX was −4.7 kcal/mol and the binding energy of bacteriocin and luxS protein was −183.701 kcal/mol. The expression of the luxS gene increased significantly after being cocultured with plantaricin YKX, suggesting that plantaricin YKX can affect the QS system of S. aureus.

1. Introduction

Staphylococcus aureus (S. aureus), one of the leading pathogenic bacteria, is able to form biofilms and can contaminate foods and medical equipment. Its biofilms are observed in processing equipment and open surfaces, resulting in disease outbreaks [1,2,3,4,5]. Compared with free cells, biofilms can not only enhance the resistance of bacteria to unpleasant environments (ultraviolet light, acid, and alkali) but also enhance the resistance of bacteria to the host immune defense system [6,7,8,9].
Chemical preservatives have often been harmful to human health [10,11,12]. Lactobacteriocin (Bactoriocins) is a class of peptide or peptide complexes produced by lactic acid bacteria (LAB) with the ability to inhibit or kill other forms similar to their proximity or living environment [13,14]. It is generally accepted as naturally nontoxic [15,16]. Many researchers have focused on the application of bacteriocins. Nisin is the first bacteriocin approved for use in food. At present, more than 45 countries have recognized nisin as a safe food preservative. As the problem of antibiotic resistance is becoming increasingly serious, people are constantly looking for drugs that can replace antibiotics against drug-resistant bacteria, among which bacteriocin is considered to have great potential. In the production of animal husbandry, with the emergence of bacteriocin and the deepening of research, it is gradually possible for bacteriocin to replace antibiotics to ensure the health of livestock and poultry, the safety of animal products and the safety of the breeding ecological environment. Bacteriocin is also often used in conjunction with other treatments and can be used as a fence to improve food safety. Regarding the study of the antibacterial activity mechanism of lactic acid bacteriocins, the literature has focused on the inhibition/killing mechanism of sensitive bacteria [10,11]. Bacteriocins can form hydrophobic “holes” in the cell membrane of sensitive bacteria, resulting in loss of cell content and cell death [17]. Furthermore, they can combine with vital proteins (enzymes) and DNA within sensitive bacteria, causing cell death [18]. Recently, some studies have found that some lactic acid bacteria can similarly affect biofilm formation in sensitive bacterial organisms [19,20]. However, a few studies have investigated the effect of bacteriocin on the quorum sensing (QS) system of sensitive bacteria.
Biofilms are composed of multilayer bacteria and extracellular polymers secreted by them. Bacteria in biofilms regulate the expression of different genes in bacteria through signal transduction between bacteria [2,3]. The bacteria in different parts of the biofilm play different physiological functions and produce synergy to maintain the spatial structure and function of the biofilm and make the biofilm become a whole with multicellular function [5]. This regulatory signaling molecule between bacteria is synthesized by the quorum sensing system, which is called autoinducer (AI) [4]. The quorum sensing system is common in bacteria. Different strains have similar regulation methods and functions. The quorum sensing system can regulate the expression of bacteria-related genes in biofilms and control the growth mode [5,6]. It is also related to the formation of biofilms. Therefore, the important role of the quorum sensing system in bacterial biofilm formation makes it a hotspot in the study of biofilm formation mechanisms.
Class IIa LAB bacteriocin plantaricin YKX (Lys-Tyr-Gly-Asn-Gly-Leu-Ser-Arg-Ile-Phe-Ser-Ala-Leu-Lys) was previously isolated, purified, and identified as a novel bacteriocin. It was found to be able to kill S. aureus and prevent biofilm formation [21]. This study aimed to investigate the mechanism of action of plantaricin YKX on S. aureus and its biofilm formation by investigating the effect of plantaricin YKX on the AI-2/LuxS QS system. It is of scientific significance to provide new perspectives and ideas for S. aureus control research and the antibacterial activity of lactic acid bacteria.

2. Materials and Methods

2.1. Materials and Strains

Plantaricin YKX was produced by Lactobacillus plantarum YKX, as described in a previous study [21]. S. aureus strains were used in this study because they are proficient in forming biofilms. LB broth (Solarbio, Beijing, China) was used to cultivate S. aureus, and MRS broth (Solarbio, Beijing, China) was used for the L. plantarum culture.

2.2. Determination of the Minimum Inhibitory Concentration (MIC)

The minimum inhibitory concentration was determined according to Clinical and Laboratory Standards (Clinical and Laboratory Standards Institute, 2012) [22]. The mid-logarithmic phase of S. aureus strains (listed in Table 1) was cocultured with planttaricin YKX at final concentrations of 256 μg/mL, 128 μg/mL, 64 μg/mL, 32 μg/mL, 16 μg/mL, 8 μg/mL, and 0 μg/mL. After 24 h of culturing at 37 °C, the first diluted concentration where S. aureus cell growth was inhibited was defined as the minimum inhibitory concentration (MIC).

2.3. Effect of Plantaricin YKX on S. aureus at Different Growth Phases

The effect of plantaricin YKX on the cells of S. aureus ATCC 25923 and S. aureus CMCC 26570 at different growth phases was investigated according to our previous work (Pei et al., 2013). Plantaricin YKX was added to a culture of S. aureus at early, middle exponential, and early stationary phases, respectively, with a final concentration of 2 MIC. Viable cell numbers were recorded every 5 h by plating onto LB agar.

2.4. Effect of Plantaricin YKX on S. aureus Cells

2.4.1. Measurement of the Extracellular K+ Ion Concentration

The leakage of K+ ions from the cells of S. aureus grown at different pH values after treatment with plantaricin YKX was determined according to Pei et al., 2013 [23]. Planticicin YKX was added to the mid-exponential phase of S. aureus grown at pH 6, pH 7, and pH 8. The change in K+out was recorded over a period of one hour with a PHG potassium ion selective electrode (Van London-pHoenix, Houston, TX, USA). The level of K+in was calculated based on the formula (K+in = K+total − K+out). Total intracellular K+ (K+total) was determined by treating cells with 10 mg/mL lysozyme at 37 °C for 30 min and determining the K+.

2.4.2. Flow Cytometry

Flow cytometry was conducted according to Pei et al., 2018 [24]. S. aureus ATCC 25,923 bacterial cells were incubated with plantaricin YKX at 1× MIC (control: cells treated without plantaricin YKX) for 1 h at 37 °C. The samples were then stained with propidium iodide (10 µg/mL) for 15 min at 37 °C. Fluorescence intensity was analyzed using an Accuri C6 flow cytometer (BD Biosciences, Ann Arbor, MI, USA) with an emission wavelength of 617 nm and an excitation wavelength of 535 nm.

2.4.3. Scanning Electron Microscope Observation of E. coli Cells

SEM was conducted according to Pei et al., 2018 [24]. Mid-logarithmic-phase S. aureus ATCC 25923 was treated with plantaricin YKX at a final concentration of 1 MIC or 2 MIC for 1 h. The samples without plantaricin YKX treatment were considered controls. After fixation with 2.5% glutaraldehyde solution, the samples were dehydrated with a serial concentration of ethanol. Then, the samples were observed with an SU-8010 field emission SEM (Hitachi High New SU8010 Series, Hitachi High-Tech Co., Ltd., Tokyo, Japan).

2.5. Effect of Plantaricin YKX on the Biofilm of S. aureus

2.5.1. Inhibitory Activity of Plantaricin YKX on S. aureus Biofilm Formation

Crystal violet staining was used to determine the inhibition of the biofilm of S. aureus according to Pei et al., 2021 [21]. Mid-logarithmic-phase S. aureus (200 μL) was added to 96-well plates. Plantaricin YKX solution was added at final concentrations of 1/4 MIC, 1/2 MIC, and 3/4 MIC (the sub-MIC concentration of plantaricin YKX was used to eliminate the possibility that the inhibition of biofilm formation was due to the cells being killed by plantaricin YKX). The isolate was cultured at 37 °C for 3 days for biofilm formation. The samples without plantaaricin YKX treatment were used as controls. The biofilms were fixed with methanol and then stained with crystal violet (2% concentration). After dropping the staining agents, 95% ethanol solution was added and shaken (100 rpm/min) for 30 min. The OD value of the supernatant (100 μL) was tested at 595 nm.

2.5.2. Confocal Laser Microscopy

Mid-logarithmic-phase S. aureus ATCC 25923 was added to plantaricin YKX at a final concentration of 1/2 MIC. The isolate was cultured at 37 °C for 3 days for biofilm formation. The samples without plantaaricin YKX treatment were used as controls. According to the manufacturer’s instructions [25], a LIVE/DEAD BacLight Bacterial Viability Kit/SYTO9/PI dye (Cell Viability, Proliferation & Function) was used to stain the samples for 30 min. Confocal laser microscopy (1000× oil lens) was used to photo the samples with a SYTO 9 excitation wavelength of 480 nm, an emission wavelength of 500 nm, a PI excitation wavelength of 490 nm, and an emission wavelength of 635 nm.

2.6. Effect of Plantaricin YKX on the QS System of S. aureus

2.6.1. Molecular Docking Was Used to Investigate the Effect of Plantaricin YKX on AI-2 Molecules and the Lux S Enzyme

Chembiodraw Ultra 14.0 (Cambridge Company, New York, NY, USA) was used to draw Al-2 of S. aureus, and Chembio3D Ultra 14.0 was used for energy minimization to set the minimum RMS gradient to 0.001 (the molecule was saved in MOL2 format). The optimized molecule was imported into AutoDockTools-1.5.6 (National Institute of Health, NIH, Bethesda, MA, USA) for hydrogenation, charge calculation, and charge distribution, and the rotatable key was set and saved in “PDBQT” format. PyMOL constructed the structure of plantaricin YKX. AutoDock Vina1.1.2 was used to dock the small molecule Al-2 with a polypeptide (plantaricin YKX), and the relevant parameters were set as follows: center_x = −6.704, center_y = 38.513, and center_z = 3.778 as central coordinates. The grid box size is 40 × 40 × 40 (the spacing of each grid is 0.375 A), and the remaining parameters are set as default.

2.6.2. Effect of Plantaricin YKX on the mRNA Expression of QS System-Related Genes (ica, lux and hld)

To verify the effect of plantaricin YKX on the QS system, RT–qPCR was used to detect the mRNA expression changes in the icaC, lux, and hld genes of S. aureus. According to the sequences of ica, lux, and hld in Geneback, primers (listed below as Table 2) were designed with Primer 5.0 software and synthesized by Shengon Bioengineering Lt. Co.Shanghai, China The mid-logarithmic phase cells of S. aureus ATCC 25923 were treated with plantaricin YKX at 1/4 MIC, 1/2 MIC, and 3/4 MIC. After overnight incubation, RNA was extracted according to the TRIzol method.
Total RNA 2 μL; DNTP 0.5 μL; random primer 0.5 μL; and 4 μL of distilled water without RNA enzyme were used to form a reverse transcription reaction system (10 μL). All samples were kept at 70 °C for 5 min and then transferred to an ice bath for preservation. Immediately added were 2 μL of 5× reverse transcription buffer, 0.5 μL of RNA enzyme inhibitor, and 0.5 μL of MMLV reverse transcriptase. Reverse transcription was performed at 30 °C for 10 min, 42 °C for 1 h, 70 °C for 15 min, and 4 °C indefinitely. After reverse transcription, the DNA template was diluted 5 times and stored at −20 °C until use.
Upstream primer (10 μM) 0.2 μL, downstream primer (10 μM) 0.2 μL, 2× Ultra SYBR Mixture 5 μL, ddH2O 3.6 μL, and DNA template 1 μL were then used for PCR amplification. 16S rRNA was used as an internal standard. The reaction parameters were 95 °C for 10 min, 95 °C for 15 s, and 60 °C for 1 min, and the cycle was 40 times.

2.7. Statistical Analyses

Data are expressed as the mean ± SD. One-way ANOVA was carried out using SPSS 18.0 (IBM, Armonk, New York, NY, USA) software, and p < 0.05 was considered statistically significant.

3. Results and Discussion

3.1. The MIC of Plantaricin YKX

The living cell number of S. aureus decreased with increasing plantaricin YMX concentration. As shown in Table 1, the minimum inhibitory concentration of plantaricin YMX against S. aureus was 16–32 μg/mL.
Generally, the MICs of bacteriocins against S. aureus are low [11,20]. The MIC is 16 μg/mL plantaricin YKX against S. aureus, which is similar to the MIC of bactreiocin SLG10 [26]. However, there are also some bacteriocins with low MICs against S. aureus; for example, the MIC of bacteriocin SLG1 is only 8 μg/mL [24]. The antibacterial activity of bacteriocins might be different with different strains. Similar results have also been found for bacteriocin Ent35-MccV [25], bacteriocin C2 [11], and bacteriocin SLG1 [24].

3.2. Effect of Plantaricin YKX on S. aureus Cells at Different Growth Phases

The addition of plantaricin YKX to an early exponential phase culture of S. aureus repressed cell growth (Figure 1). Similar inhibition was observed when plantaricin YKX was added to the mid-exponential and stationary phase cultures (Figure 1). The inhibitory effect of plantaricin YKX was not affected by the difference in the strains of S. aureus.
The growth phases of sensitive bacteria might affect the resistance to bacteriocins because in different growth phases, there might be differences in the detailed compositions of cell membranes. Several bacteriocins reported that the antibacterial activity exhibited differences according to the different growth phases of the sensitive bacteria [27]. However, similar to plantaricin YKX in this study, many bacteriocin antibacterial abilities were not affected by the growth phases of sensitive bacteria, such as bacteriocin SLG10 [26], bacteriocin Ent35-MccV [25], and plantaricin K25 [18].

3.3. Effect of Plantaricin YKX on S. aureus Cells

After the addition of plantaricin YKX, K+ was immediately and rapidly effluxed, followed by a later slow release (Figure 2). With the addition of plantaricin YKX, cells incubated at pH 8.0 lost the least K+ during 1 h (Figure 2), and cells incubated at pH 7.0 lost the lowest K+ concentration for the next hour. The efflux rate decreased significantly as the extracellular pH dropped to 6 (Figure 2).
The percentage of dead bacteria in the control group was 0.24%, while it was 11.5% for the ATCC 25923 strain and 12.4% for CMCC 26570 after treatment with plantaricin YKX (Figure 3). The results indicated that plantaricin YKX has antibacterial activity against S. aureus ATCC.
As shown in Figure 4, compared to the untreated S. aureus cells, the cells treated with plantaricin YKX showed obvious damage. SEM images indicate that plantaricin YKX might form pores on cell membranes, leading to the release of cytoplasmic components. The SEM observation results are consistent with the leakage of potassium testing and the flow cytometry test.
Our results suggest that plantaricin YKX acts on the cytoplasmic membrane of S. aureus. The generation of antibacterial activity may be due to the creation of pores in the cell membrane. The observation of K+ loss showed that pH is one of the important factors affecting the ability of plantaricin YKX to form pores in S. aureus cell membranes. The highest rate of bacteriocin-induced K+ loss was observed at pH 6. As observed for several other bacteriocins, ΔpH may contribute to the action of bacteriocins (under physiological conditions) [23,27].
Flow cytometry analysis revealed that plantaricin YKX mediated cell membrane destruction and eventually led to cell death. Similar results were reported for nisin, plantaricin K25 [28], bifidocin A [18], and enterocin 7A and 7B [29].
Based on the current literature, we know that cell membrane permeability plays an important role in the mode of action of bacteriocins. In this study, plantaricin YKX led to pore formation and eventual cell death, demonstrating the ability to increase cell membrane permeability. Similar mechanisms were observed with plantaricin 163 [30], bifidocin A, and bacteriocin Ent35-MccV [25,29].

3.4. Inhibition of Biofilm Formation by Plantaricin YKX

As shown in Figure 5, the sub-MIC concentration of plantaricin YKX inhibited the formation of biofilms of S. aureus ATCC 25923, and the rates of plantaricin YKX inhibition of S. aureus biofilm formation reached 16.3%, 46.6%, and 56.1% at 0.25× MIC, 0.5× MIC, and 0.75× MIC, respectively.
Fluorescent probe staining was used for the observation and measurement of bacterial adhesion. As shown in Figure 6, there were fewer biofilm adhesion bacteria in the presence of plantaricin YKX. The bacterial colonies in the control were dense, and the number of live bacteria within the biofilm was obviously higher than those treated with plantaricin YKX.
It is hypothesized that 99% of bacteria can exist in the form of biofilms [31]. Biofilm formation is also one of the important factors contributing to food contamination, and plantaricin YKX may provide a new idea to prevent food contamination by pathogens or spoilage bacteria by inhibiting biofilm formation. Previous studies on the mode of action of lactic acid bacteria bacteriocins have focused on the effect of bacteriocins on sensitive bacterial cells, and some recent studies have suggested that bacteriocins may also affect biofilm formation in sensitive bacteria [20,31].

3.5. Effect of Plantaricin YKX on the AI-2/Lux S QS System of S. aureus

The binding energy of AI-2 and plantaricin YKX is −4.7 kcal/mol, which proves that Al-2 has a good binding effect. Al-2 interacts with plantaricin YKX mainly through hydrogen bonding and forms a hydrogen bond with S7 with an A length of 3.0 Å (Figure 7).
The expression of the luxS and icaC genes of S. aureus ATCC 25923 increased significantly (p < 0.05) after being cocultured with plantaricin YKX at 1/4× MIC, 1/2× MIC, and 3/4× MIC (Figure 8). However, the expression of the hld genes of S. aureus ATCC 25923 after plantaricin YKX treatment was not changed significantly (p > 0.05) (Figure 8C).
QS systems are one of the research hotspots in the field of microbiology. It can be divided into three types: (1) LuxS/Al-2-dependent QS systems; (2) oligopeptide-mediated two-component sensing systems in Gram-positive bacteria; and (3) AHL lux I/Lux R systems in Gram-negative bacteria [7]. QS systems are related to bacterial species in many-to-one manners. For example, LuxS/AI-2-dependent QS systems are present in both Gram-positive and Gram-negative bacteria, where AI-2 is a universal signaling molecule involved in information exchange [4]. Due to bacterial swarming, the LuxS/AI-2-dependent QS system and AI-2 molecules are essential for bacteria to form a relatively stable ecological environment for bacterial population and functional division. It is closely linked to biological functions such as bacteriocin synthesis, biofilm formation, and virulence factor expression.
In the initial stage of biofilm formation, polysaccharide intercellular adhesin (PIA) encoded by the icaadb operon is an important mediator in the aggregation stage [7]. The formation of biofilms depends on the expression of the ica gene and PIA synthesis [4]. Staphylococcus has a unique and complete system. The arg and luxS genes are the key genes in the regulation mechanism of QS [6]. The agr gene is responsible for the dependent regulation of the growth stage of virulence factors. The agr system can regulate the adhesion of the bacterial surface. The agr system consists of two different transcription units, RNA II and RNA III. RNA III is also the messenger RNA of the hld gene, which encodes D toxin [8]. Another QS system of Staphylococcus, the LuxS system, can downregulate PIA products, an important mediator in the aggregation stage [32]. Therefore, the QS system of Staphylococcus plays an important role in the biofilm formation of bacteria.
All AI-2 is a byproduct of the methyl cycle. LuxS protein, a key and essential enzyme for Al-2 synthesis, plays an important role in the methyl cycle [4]. We evaluated the effect of plantaricin YKX on icaC, luxS, and hld gene expression. The results indicate that plantaricin YKX has a positive effect on icaC and luxS gene expression. Previous studies on the mode of action of bacteriocins have focused on the mechanism of bacteriocins on susceptible bacteria [18,29], while little has been reported on the effect on the QS system of susceptible bacteria. The results of the present study suggest that the conclusion of the effect on the QS system of susceptible bacteria does not hold for all bacteriocins; plantaricin YKX does, but nisin does not [21]. Thus, the mode of action of bacteriocins seems to be diverse. Similar reports have been mentioned, for example, for plantaricin K25 [18], bifidocin A [29], plantaricin 163 [30], and plantaricin JLA-9 [33].

4. Conclusions

In this study, the inhibitory mode of action of plantaricin YKX on S. aureus was investigated. The MIC of plantaricin YKX against S. aureus was 16 μg/mL. After treatment with sub-MIC plantaricin YKX, living cells in the biofilm of S. aureus were significantly decreased. Confocal laser microscopy showed that 1/2 MIC plantaricin YKX was able to inhibit the formation of biofilms. Molecular docking suggested that plantaricin YKX was able to bind with AI-2 molecules and its synthesis enzyme Lux S. Additionally, plantaricin YKX was also able to affect the gene expression of the QS system-related gene. Through the results, the conclusion can be obtained that plantaricin YKX was not only able to damage the cell membrane of S. aureus but also able to regulate its QS system.

Author Contributions

J.P.: conceptualization, design of the work, visualization, resources, funding acquisition, and writing—review & editing. Y.H.: acquisition, resources, investigation, formal analysis, and writing. T.R.: the acquisition, Resources, Investigation, Formal analysis. Y.G., J.D.: Supervision, conception or design of the work, Resources, Investigation. Y.T., Y.Z.: supervision, resources, investigation, formal analysis. A.M.A.E.-A.: Data acquisition, formal analysis, conceptualization, writing—review & editing. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by a Special Support Plan for High-Level Talents in Shaanxi Province (for Jinjin Pei), the Foreign Expert Project of the Ministry of Science and Technology (G2021041001, DL2021041001 and QN2021041001) and the Research Project of Shaanxi Provincial Department of Science and Technology (2021JZY003).

Institutional Review Board Statement

Not applicable for this study.

Informed Consent Statement

Not applicable.

Data Availability Statement

All the data are included in this manuscript.

Acknowledgments

We confirmed that there are no known conflicts of interest associated with this publication.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Tong, S.Y.; Davis, J.S.; Eichenberger, E.; Holland, T.L.; Fowler, V.G. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015, 28, 603–661. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Bajaj, T.; Karapetians, A.; Karapetians, N.; Duong, H.; Heidari, A. Methicillin resistant Staphylococcus aureus infective endocarditis presenting as neutrophilic meningoencephalitis. AME Case Rep. 2020, 4, 4e. [Google Scholar] [CrossRef] [PubMed]
  3. Muñoz-Silvestre, A.; Penadés, M.; Selva, L.; Pérez-Fuentes, S.; Moreno-Grua, E.; García-Quirós, A.; Pascual, J.J.; Arnau-Bonachera, A.; Barragán, A.; Corpa, J.M.; et al. Pathogenesis of intradermal staphylococcal infections: Rabbit experimental approach to natural Staphylococcus aureus skin infections. Am. J. Pathol. 2020, 190, 1188–1210. [Google Scholar] [CrossRef] [PubMed]
  4. Hall-Stoodley, L.; Costerton, J.; Stoodley, P. Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2, 95–108. [Google Scholar] [CrossRef]
  5. Gutiérrez, D.; Rodríguez-Rubio, L.; García, P.; Billington, C.; Premarante, A.; Rodríguez, A.; Martínez, B. Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand. Int. J. Food Microbiol. 2016, 230, 16–20. [Google Scholar] [CrossRef] [Green Version]
  6. Archer, N.K.; Mazaitis, M.J.; Costerton, J.W.; Leid, J.G.; Powers, M.E.; Shirtliff, M.E. Staphylococcus aureus biofilms. Virulence 2011, 2, 445–459. [Google Scholar] [CrossRef] [Green Version]
  7. Flemming, H.C.; Wingender, J.; Szewzyk, U.; Steinberg, P.; Rice, S.A.; Kjelleberg, S. Biofifilms: An emergent form of bacterial life. Nat. Rev. Microbiol. 2016, 14, 563–575. [Google Scholar] [CrossRef]
  8. Römling, U.; Balsalobre, C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med. 2012, 272, 541–561. [Google Scholar] [CrossRef]
  9. Srivastava, S.; Bhargava, A. Biofilms and human health. Biotechnol. Lett. 2016, 38, 1–22. [Google Scholar] [CrossRef]
  10. Amit, S.K.; Uddin, M.M.; Rahman, R.; Islam, S.M.R.; Khan, M.S. A review on mechanisms and commercial aspects of food preservation and processing. Agric. Food Secur. 2017, 6, 51. [Google Scholar] [CrossRef]
  11. Gao, Y.; Jia, S.; Gao, Q.; Tan, Z. A novel bacteriocin with a broad inhibitory spectrum produced by Lactobacillus sake C2, isolated from traditional Chinese fermented cabbage. Food Control 2010, 21, 76–81. [Google Scholar] [CrossRef]
  12. Pei, J.J.; Feng, Z.Z.; Ren, T.; Sun, H.Y.; Hao, H.; Jin, W.G.; Dang, J.; Tao, Y.D. Purification, characterization and application of a novel antibacterial peptide from Andrias davidianus blood. Lett. Appl. Microbiol. 2017, 66, 38–43. [Google Scholar] [CrossRef]
  13. Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocins—A viable alternative to antibiotics? Nat. Rev. Microbiol. 2013, 11, 95–105. [Google Scholar] [CrossRef]
  14. Cotter, P.D.; Hill, C.; Ross, R.P. Bacteriocins: Developing innate immunity for food. Nat. Rev. Microbiol. 2005, 3, 777–788. [Google Scholar] [CrossRef]
  15. Gálvez, A.; López, R.L.; Pulido, R.P.; Burgos, M.J.G. Application of Lactic Acid Bacteria and Their Bacteriocins for Food Biopreservation. In Food Biopreservation; Springer: New York, NY, USA, 2014; pp. 15–22. [Google Scholar]
  16. Asioli, D.; Aschemann-Witzel, J.; Caputo, V.; Vecchio, R.; Annunziata, A.; Næs, T.; Varela, P. Making sense of the “clean label” trends: A review of consumer food choice behavior and discussion of industry implications. Food Res. Int. 2017, 99, 58–71. [Google Scholar] [CrossRef]
  17. Gálvez, A.; López, R.; Abriouel, H.; Valdivia, E.; Omar, N.B. Application of bacteriocins in the control of foodborne pathogenic and spoilage bacteria. Crit. Rev. Biotechnol. 2008, 28, 125–152. [Google Scholar] [CrossRef]
  18. Wen, L.S.; Philip, K.; Ajam, N. Purification, characterization and mode of action of plantaricin K25 produced by Lactobacillus plantarum. Food Control 2016, 60, 430–439. [Google Scholar] [CrossRef]
  19. Pang, X.; Song, X.; Chen, M.; Tian, S.; Lu, Z.; Sun, J.; Li, X.; Lu, Y.; Yuk, H. Combating biofilms of foodborne pathogens with bacteriocins by lactic acid bacteria in the food industry. Compr. Rev. Food Sci. Food Saf. 2022, 21, 1657–1676. [Google Scholar] [CrossRef]
  20. Kim, N.N.; Kim, W.J.; Kang, S.S. Anti-biofilm effect of crude bacteriocin derived from Lactobacillus brevis DF01 on Escherichia coli and Salmonella Typhimurium. Food Control 2019, 98, 274–280. [Google Scholar] [CrossRef]
  21. Pei, J.; Jin, W.; Wang, J.; Huang, Y.; Li, X.; Zhang, H.; Zhang, Y.; Ramadan, A.; El-Aty, A.M.A. Purification and Characterization of Plantaricin YKX and Assessment of Its Inhibitory Activity Against Alicyclobacillus spp. Front. Microbiol. 2021, 12, 783266. [Google Scholar] [CrossRef]
  22. Clinical and Laboratory Standards Institute. Methods for Dilution Antibacterial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standards, 9th ed.; Document M07-A9; CLSI: Wayne, PA, USA, 2012. [Google Scholar]
  23. Pei, J.; Yuan, Y.; Yue, T. Primary characterization of bacteriocin paracin C—A novel bacteriocin produced by Lactobacillus paracasei. Food Control 2013, 34, 168–176. [Google Scholar] [CrossRef]
  24. Pei, J.J.; Li, X.S.; Han, H.; Tao, Y.D. Purification and characterization of plantaricin SLG1, a novel bacteriocin produced by Lb. plantarum isolated from yak cheese. Food Control 2018, 84, 111–117. [Google Scholar] [CrossRef]
  25. Acuna, L.; Picariello, G.; Sesma, F.; Morero, R.D.; Bellomio, A. A new hybrid bacteriocin, Ent35-MccV, displays antibacterial activity against pathogenic Gram-positive and Gram-negative bacteria. FEBS Open Bio 2012, 2, 12–19. [Google Scholar] [CrossRef] [Green Version]
  26. Pei, J.; Jin, W.; Abd El-Aty, A.M.; Baranenko, D.A.; Gou, X.; Zhang, H.; Geng, J.; Jiang, L.; Chen, D.; Yue, T. Isolation, purification, and structural identification of a new bacteriocin made by Lactobacillus plantarum found in conventional kombucha. Food Control 2020, 110, 106923. [Google Scholar] [CrossRef]
  27. Todorov, S.D.; Prévost, H.; Lebois, M.; Dousset, X.; LeBlanc, J.G.; Franco, B.D.G.M. Bacteriocinogenic Lactobacillus plantarum ST16 Pa isolated from papaya (Carica papaya)—From isolation to application: Characterization of a bacteriocin. Food Res. Int. 2011, 44, 1351–1363. [Google Scholar] [CrossRef]
  28. Lohans, C.T.; Towle, K.M.; Miskolzie, M.; McKay, R.T.; van Belkum, M.J.; McMullen, L.M.; Vederas, J.C. Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide. Biochem.-US 2013, 52, 3987–3994. [Google Scholar] [CrossRef]
  29. Liu, G.; Song, Z.; Yang, X.; Gao, Y.; Wang, C.; Sun, B. Antibacterial mechanism of bifidocin A, a novel broad-spectrum bacteriocin produced by Bifidobacterium animalis BB04. Food Control 2016, 62, 309–316. [Google Scholar] [CrossRef]
  30. Hu, M.; Zhao, H.; Zhang, C.; Yu, J.; Lu, Z. Purification and characterization of plantaricin 163, a novel bacteriocin produced by Lactobacillus plantarum 163 isolated from traditional Chinese fermented vegetables. J. Agric. Food Chem. 2013, 61, 11676–11682. [Google Scholar] [CrossRef]
  31. Winkelströter, L.K.; Tulini, F.L.; De Martinis, E.C.P. Identification of the bacteriocin produced by cheese isolate Lactobacillus paraplantarum, FT259 and its potential influence on Listeria monocytogenes, biofilm formation. LWT-Food Sci. Technol. 2015, 64, 586–592. [Google Scholar] [CrossRef]
  32. Houry, A.; Briandet, R.; Aymerich, S.; Gohar, M. Involvement of motility and flagella in Bacillus cereus biofilm formation. Microbiology 2010, 156, 1009–1018. [Google Scholar] [CrossRef] [Green Version]
  33. Zhao, S.M.; Han, J.Z.; Bie, X.M.; Lu, Z.X.; Zhang, C.; Lv, F.X. Purification and characterization of plantaricin JLA-9: A novel bacteriocin against Bacillus spp. produced by Lactobacillus plantarum JLA-9 from Suan-Tsai, a traditional Chinese fermented cabbage. J. Agric. Food Chem. 2016, 64, 2754–2764. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Inhibitory kinetics of plantaricin YKX against S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B). (): Control (without plantaricin YKX treatment); plantaricin YKX was added at the early-stage phase (●), at the mid-exponential phase (), and the stationary phase ().
Figure 1. Inhibitory kinetics of plantaricin YKX against S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B). (): Control (without plantaricin YKX treatment); plantaricin YKX was added at the early-stage phase (●), at the mid-exponential phase (), and the stationary phase ().
Molecules 27 04280 g001
Figure 2. Efflux of K+ from cells of S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B) after treatment with plantaricin YKX at pH 8 (●), pH 7 (▲), and pH 6 (■).
Figure 2. Efflux of K+ from cells of S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B) after treatment with plantaricin YKX at pH 8 (●), pH 7 (▲), and pH 6 (■).
Molecules 27 04280 g002
Figure 3. Flow cytometry results of S. aureus ATCC 25923 without (A) and with (B) plantaricin YKX treatment.
Figure 3. Flow cytometry results of S. aureus ATCC 25923 without (A) and with (B) plantaricin YKX treatment.
Molecules 27 04280 g003
Figure 4. Effect of plantaricin YKX on the cell structure of S. aureus ATCC 25923. (A): without plantaricin YKX treatment; (B): after treatment with 1 MIC plantaricin YKX for 30 min; (C): after treatment with 1 MIC plantaricin YKX for 2 h.
Figure 4. Effect of plantaricin YKX on the cell structure of S. aureus ATCC 25923. (A): without plantaricin YKX treatment; (B): after treatment with 1 MIC plantaricin YKX for 30 min; (C): after treatment with 1 MIC plantaricin YKX for 2 h.
Molecules 27 04280 g004
Figure 5. Effect of plantaricin YKX on S. aureus biofilm formation. S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B). * significant. p < 0.05; ** highly significant. p < 0.01.
Figure 5. Effect of plantaricin YKX on S. aureus biofilm formation. S. aureus ATCC 25923 (A) and S. aureus CMCC 26570 (B). * significant. p < 0.05; ** highly significant. p < 0.01.
Molecules 27 04280 g005
Figure 6. Confocal laser observation of biofilms of S. aureus treated without (Up) and with (Down) 3/4 MIC plantaricin YKX.
Figure 6. Confocal laser observation of biofilms of S. aureus treated without (Up) and with (Down) 3/4 MIC plantaricin YKX.
Molecules 27 04280 g006
Figure 7. Docking results of plantaricin YKX with Al-2 of S. aureus. (Left): homology modeling results. (Right): docking results.
Figure 7. Docking results of plantaricin YKX with Al-2 of S. aureus. (Left): homology modeling results. (Right): docking results.
Molecules 27 04280 g007
Figure 8. Effect of plantaricin YKX on the relative expression of QS system-related genes. (A): icaC; (B): hld; (C): luxS. * significant. p < 0.05; ** highly significant. p < 0.01.
Figure 8. Effect of plantaricin YKX on the relative expression of QS system-related genes. (A): icaC; (B): hld; (C): luxS. * significant. p < 0.05; ** highly significant. p < 0.01.
Molecules 27 04280 g008aMolecules 27 04280 g008b
Table 1. MIC of plantaricin YKX against S. aureus.
Table 1. MIC of plantaricin YKX against S. aureus.
Strains of S. aureusMIC
S. aureus CMCC 2656016 μg/mL
S. aureus CMCC 2656316 μg/mL
S.aureus CMCC 2656516 μg/mL
S. aureus CMCC 2657016 μg/mL
S. aureus CMCC 2657332 μg/mL
S. aureus CMCC 2658116 μg/mL
S. aureus CMCC 2659032 μg/mL
S. aureus CMCC 2657516 μg/mL
S.aureus CMCC 2658516 μg/mL
S. aureus CMCC 2657916 μg/mL
S. qureus ATCC 2592316 μg/mL
Table 2. Primers used in this study.
Table 2. Primers used in this study.
GenePrimers (5′-3′)
luxF: TCCTATGGGTTGTCAAACTGG
R: CCTTCTCCGTAGATGTCATTCC
icaCF: TGCTTACACCAACATATTTGAAGATAATAC
R: GACGCCTATACAAATTCCTAGAATCATT
hldF: GAAGTTATGATGGCAGCAGAT
R: GTTGGGATGGCTCAACAACT
16S rRNAF: GCGGTCGCCTCCTAAAAG
R: TCCCGGTCCTCTCGTACTA
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pei, J.; Huang, Y.; Ren, T.; Guo, Y.; Dang, J.; Tao, Y.; Zhang, Y.; Abd El-Aty, A.M. The Antibacterial Activity Mode of Action of Plantaricin YKX against Staphylococcus aureus. Molecules 2022, 27, 4280. https://doi.org/10.3390/molecules27134280

AMA Style

Pei J, Huang Y, Ren T, Guo Y, Dang J, Tao Y, Zhang Y, Abd El-Aty AM. The Antibacterial Activity Mode of Action of Plantaricin YKX against Staphylococcus aureus. Molecules. 2022; 27(13):4280. https://doi.org/10.3390/molecules27134280

Chicago/Turabian Style

Pei, Jinjin, Yigang Huang, Ting Ren, Yaodong Guo, Jun Dang, Yanduo Tao, Yonggui Zhang, and A. M. Abd El-Aty. 2022. "The Antibacterial Activity Mode of Action of Plantaricin YKX against Staphylococcus aureus" Molecules 27, no. 13: 4280. https://doi.org/10.3390/molecules27134280

Article Metrics

Back to TopTop